Mr Sam Santhosh is an entrepreneur with over 25 years of experience in initiating and running successful businesses.
Sam is currently the Chairman and CEO of MedGenome Inc - a genomics-based research and diagnostics company delivering the best of health care by decoding genetic information contained in an individual’s genome. MedGenome is the first mover and market leader in genomics-based diagnostics and research from India with international offices in San Francisco and Boston.
Sam is an investor and mentor for many companies and is currently a board member at Impelsys Inc, New York, ePay Healthcare, San Francisco, SciGenom Labs, Cochin, Emerge Ventures, Singapore and the Centre for Commercialization of Antibodies (CCAB) Toronto, Canada
Prior to this Sam was the CEO and Managing Director of California Software Limited (Calsoft) from 1992 - Feb 2012. He founded Calsoft in 1992 and under Sam's vision Calsoft rapidly grew from a niche player in the Silicon Valley to a global player with over 1200 employees and presence in 8 countries. Sam took Calsoft public and listed the company in the Indian Stock Exchanges. From 2004 to 2009, Sam focused on inorganic growth through eight acquisitions including companies in U.S, UK, Japan and India. Post 2009, he oversaw the sale of the Calsoft group companies to different buyers across the world.
He has been constantly retooling himself and has attended various training programs in different U.S universities including MIT. In 2010, he completed the Executive Education program at the Singularity University in Sunnyvale, California. Sam has an engineering degree and an MBA (majoring in Management Information Systems) from India's premier institute, IIM Calcutta.